AstraZeneca's Legal Troubles Continue To Mount
Lawsuits continue to trickle in alleging that AstraZeneca has illegally controlled the market by shifting its support to Nexium from Prilosec as Prilosec lost patent protection.
Two suits were filed this week in the U.S. District Court for the District of Columbia. Louisiana Wholesale Drug Co. Inc., a wholesaler which reportedly covers 65% of independent...
To view the full article, register now.